(NTR) Nutrien - Ratings and Ratios
Fertilizer, Crop Protection, Seed, Nutrient, Services
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.7% |
| Value at Risk 5%th | 42.9% |
| Relative Tail Risk | -2.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 19.34 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.406 |
| Beta | 0.407 |
| Beta Downside | 0.450 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.33% |
| Mean DD | 28.20% |
| Median DD | 29.54% |
Description: NTR Nutrien October 14, 2025
Nutrien Ltd. (NYSE: NTR) is the world’s largest provider of crop inputs and services, organized into four operating segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. The Ag Solutions arm sells nutrients, crop-protection chemicals, seeds and related merchandise, and also delivers agronomic services such as soil and leaf testing, precision-ag technology, water management, and financing to growers.
The Potash segment produces both granular and standard potash fertilizers, while the Nitrogen segment offers a portfolio that includes ammonia, urea, “environmentally smart” nitrogen products, nitrates and sulfates. The Phosphate segment supplies solid and liquid phosphate fertilizers as well as industrial and feed-grade phosphate products.
Key financial and operational metrics (2023) include roughly $27 billion in revenue, an EBITDA margin near 15 %, and net debt of about $6 billion. Production capacity is roughly 14 million tonnes of potash, 10 million tonnes of nitrogen, and 6 million tonnes of phosphate, positioning the firm to meet a sizable share of global fertilizer demand.
Primary economic drivers for Nutrien are global grain and oilseed production growth (which fuels fertilizer consumption), commodity price cycles for nitrogen, potash and phosphate, and regulatory trends that incentivize lower-emission nitrogen use. A sector-wide catalyst is the accelerating adoption of precision agriculture and digital agronomy services, which can boost the value of Nutrien’s Ag Solutions offerings.
For a deeper quantitative dive into Nutrien’s valuation metrics and scenario analysis, the ValueRay platform offers a free, data-rich snapshot worth exploring.
NTR Stock Overview
| Market Cap in USD | 27,367m |
| Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception | 2018-01-02 |
| Return 12m vs S&P 500 | 10.6% |
| Analyst Rating | 3.88 of 5 |
NTR Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 3.87% |
| Yield on Cost 5y | 5.21% |
| Yield CAGR 5y | 4.66% |
| Payout Consistency | 100.0% |
| Payout Ratio | 53.8% |
NTR Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -8.33% |
| CAGR/Max DD Calmar Ratio | -0.19 |
| CAGR/Mean DD Pain Ratio | -0.30 |
| Current Volume | 3063.4k |
| Average Volume | 2115.1k |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (1.80b TTM) > 0 and > 6% of Revenue (6% = 1.59b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -0.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.82% (prev 10.98%; Δ 4.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 4.14b > Net Income 1.80b (YES >=105%, WARN >=100%) |
| Net Debt (13.56b) to EBITDA (5.61b) ratio: 2.42 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (485.8m) change vs 12m ago -1.84% (target <= -2.0% for YES) |
| Gross Margin 30.19% (prev 29.06%; Δ 1.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 51.20% (prev 51.16%; Δ 0.04pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.66 (EBITDA TTM 5.61b / Interest Expense TTM 691.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.68
| (A) 0.08 = (Total Current Assets 14.47b - Total Current Liabilities 10.27b) / Total Assets 51.83b |
| (B) 0.23 = Retained Earnings (Balance) 11.84b / Total Assets 51.83b |
| (C) 0.06 = EBIT TTM 3.22b / Avg Total Assets 51.87b |
| (D) 0.94 = Book Value of Equity 25.06b / Total Liabilities 26.67b |
| Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.96
| 1. Piotroski 6.0pt |
| 2. FCF Yield 5.42% |
| 3. FCF Margin 8.35% |
| 4. Debt/Equity 0.56 |
| 5. Debt/Ebitda 2.42 |
| 6. ROIC - WACC (= 1.14)% |
| 7. RoE 7.31% |
| 8. Rev. Trend -15.01% |
| 9. EPS Trend -25.59% |
What is the price of NTR shares?
Over the past week, the price has changed by -1.33%, over one month by -3.32%, over three months by -2.60% and over the past year by +25.30%.
Is NTR a buy, sell or hold?
- Strong Buy: 10
- Buy: 5
- Hold: 8
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the NTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65.7 | 16.9% |
| Analysts Target Price | 65.7 | 16.9% |
| ValueRay Target Price | 60 | 6.7% |
NTR Fundamental Data Overview November 25, 2025
P/E Trailing = 15.1456
P/E Forward = 11.5207
P/S = 1.0661
P/B = 1.0813
P/EG = 0.6101
Beta = 1.146
Revenue TTM = 26.56b USD
EBIT TTM = 3.22b USD
EBITDA TTM = 5.61b USD
Long Term Debt = 9.85b USD (from longTermDebt, last quarter)
Short Term Debt = 3.37b USD (from shortTermDebt, last quarter)
Debt = 14.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.56b USD (from netDebt column, last quarter)
Enterprise Value = 40.92b USD (27.37b + Debt 14.18b - CCE 624.0m)
Interest Coverage Ratio = 4.66 (Ebit TTM 3.22b / Interest Expense TTM 691.6m)
FCF Yield = 5.42% (FCF TTM 2.22b / Enterprise Value 40.92b)
FCF Margin = 8.35% (FCF TTM 2.22b / Revenue TTM 26.56b)
Net Margin = 6.79% (Net Income TTM 1.80b / Revenue TTM 26.56b)
Gross Margin = 30.19% ((Revenue TTM 26.56b - Cost of Revenue TTM 18.54b) / Revenue TTM)
Gross Margin QoQ = 32.70% (prev 30.42%)
Tobins Q-Ratio = 0.79 (Enterprise Value 40.92b / Total Assets 51.83b)
Interest Expense / Debt = 1.19% (Interest Expense 168.1m / Debt 14.18b)
Taxrate = 26.37% (166.1m / 629.9m)
NOPAT = 2.37b (EBIT 3.22b * (1 - 26.37%))
Current Ratio = 1.41 (Total Current Assets 14.47b / Total Current Liabilities 10.27b)
Debt / Equity = 0.56 (Debt 14.18b / totalStockholderEquity, last quarter 25.12b)
Debt / EBITDA = 2.42 (Net Debt 13.56b / EBITDA 5.61b)
Debt / FCF = 6.12 (Net Debt 13.56b / FCF TTM 2.22b)
Total Stockholder Equity = 24.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.48% (Net Income 1.80b / Total Assets 51.83b)
RoE = 7.31% (Net Income TTM 1.80b / Total Stockholder Equity 24.66b)
RoCE = 9.33% (EBIT 3.22b / Capital Employed (Equity 24.66b + L.T.Debt 9.85b))
RoIC = 6.38% (NOPAT 2.37b / Invested Capital 37.15b)
WACC = 5.24% (E(27.37b)/V(41.55b) * Re(7.51%) + D(14.18b)/V(41.55b) * Rd(1.19%) * (1-Tc(0.26)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.92%
[DCF Debug] Terminal Value 71.70% ; FCFE base≈2.26b ; Y1≈1.57b ; Y5≈801.3m
Fair Price DCF = 32.02 (DCF Value 15.48b / Shares Outstanding 483.3m; 5y FCF grow -35.86% → 3.0% )
EPS Correlation: -25.59 | EPS CAGR: -23.41% | SUE: 0.30 | # QB: 0
Revenue Correlation: -15.01 | Revenue CAGR: -8.27% | SUE: 0.84 | # QB: 0
Additional Sources for NTR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle